Association of Familial Fanconi Syndrome with a Novel GATM Variant.

Fanconi syndrome is a disorder of the proximal renal tubule. Recently, advanced genetic analysis technology has revealed that several genes cause familial Fanconi syndrome. We identified a family with autosomal dominant Fanconi syndrome and chronic kidney disease with a novel glycine amidinotransferase (GATM) variant. Case 1 was a 57-year-old Japanese woman. Her father and two siblings had Fanconi syndrome or chronic kidney disease. She presented to our hospital at the age of 34 years with recurrent glucosuria. Her height and weight were 151 cm and 46.6 kg, respectively. Laboratory tests showed glucosuria, hypophosphatemia, hypouricemia, and normal renal function. Her serum creatinine level gradually increased over the following next two decades, and she developed end-stage renal disease. Case 2, the daughter of Case 1, was a 26-year-old woman. Her height and weight were 151 cm and 37.5 kg, respectively. Glucosuria was detected at the age of 13 years, which led to a referral to our hospital. Urinalysis showed low-molecular-weight proteinuria. She was diagnosed with Fanconi syndrome. At the age of 26 years, she had glucosuria, low-molecular-weight proteinuria, hypouricemia, and normal renal function. Genetic testing of both cases revealed a novel missense variant in GATM. The heterozygous missense variants in GATM have been reported to cause familial Fanconi syndrome, which manifests early in life and progresses to renal glomerular failure by mid-adulthood. The novel GATM variant detected in our cases was suspected to be associated with the development of Fanconi syndrome. GATM variants should be tested in patients with idiopathic Fanconi syndrome.

Photocatalytic formation of a gas permeable layer selectively deposited on supported metal nanoparticles for sintering-resistant thermal catalysis.

Nanoparticle aggregation of supported metal catalysts at high temperatures is a serious problem that causes a drop in catalytic performance. This study investigates the protection of metal nanoparticles from sintering by selectively forming nanoscale SiO2 shells on Pd supported on TiO2 by ultraviolet (UV) light irradiation. The proton-coupled reduction reaction increases the local pH around Pd nanoparticles, resulting in hydrolysis of tetraethoxyorthosilicate (TEOS) in only the vicinity of the metal. An apparent quantum efficiency of only 0.6% is obtained for the Pd/TiO2 catalyst in H2 evolution from ethanol-containing water under 370 nm excitation light. Therefore, the pH of raw slurry solution should be precisely controlled to that slightly below the threshold value for the TEOS hydrolysis reaction before the photodeposition. Transmission electron microscopy (TEM) and energy dispersive X-ray spectroscopy (EDX) clearly show that the particle size of the Pd nanoparticles (∼40 nm) with the SiO2 shell (∼20 nm) was almost unchanged by the high-temperature treatment at 900 °C in air, suggesting that the SiO2 shell prevented thermal aggregation of Pd nanoparticles. The Pd/TiO2 without SiO2 shell decoration exhibited a drop in the number of active sites, which was likely due to aggregation of the Pd catalysts. However, the number of active sites on the Pd@SiO2/TiO2 catalyst was maintained even after the catalyst was calcined at 900 °C. Consequently, the Pd@SiO2/TiO2 catalyst maintained its catalytic performance for simulated exhaust gas purification even after treatment at 900 °C. This study presents a methodology to produce sintering-tolerant supported metal nanoparticles using the photocatalytic gas permeable layer fabrication method.

Perovskite lattice oxygen contributes to low-temperature catalysis for exhaust gas cleaning.

A Pd catalyst supported on Ba-substituted LaAlO3 perovskite (Pd/La0.9Ba0.1AlO3-δ ) was investigated for NO reduction at low temperature by propylene, which revealed that Pd/La0.9Ba0.1AlO3-δ has remarkably higher activity than other Pd catalysts at low temperatures (≤573 K) for NO reduction by propylene. To elucidate the surface reaction pathway, transient response tests were conducted using 18O2. Also, X-ray photoelectron spectroscopy (XPS) and diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) measurements were conducted. Comparison with a Ba-impregnated catalyst (Pd/Ba/LaAlO3) demonstrated that Pd/La0.9Ba0.1AlO3-δ shows higher activity for the formation of oxygenated species (C x H y O z ) as an intermediate for NO reduction because the surface lattice oxygen has improved mobility via Ba2+ substitution in LaAlO3. Therefore, Pd/La0.9Ba0.1AlO3-δ have high activity for NO reduction, even at low temperatures in a humid condition.

Elevated serum levels of neutrophil elastase in patients with influenza virus-associated encephalopathy.

We examined serum levels of various cytokines, chemokines, growth factors, and adhesion molecules in patients with uncomplicated influenza (n=20) and influenza virus-associated encephalopathy (IE) (n=18) to understand the underlying mechanism of IE. We found that IL-1ß, IL-2, IL-5, IL-6, IL-7, IL-8, IL-10, IL-13, G-CSF, GM-CSF, TNF-α, TIMP-1, MMP-9, sE-selectin, and neutrophil elastase were elevated significantly in sera from patients with uncomplicated influenza and those with IE, compared with normal controls (n=20). Of note, neutrophil elastase, sE-selectin, IL-8, and IL-13 were elevated significantly in IE as compared with uncomplicated influenza. In the present study, for the first time, we found that serum levels of neutrophil elastase were increased in patients with IE compared with uncomplicated influenza, which suggested that cerebral endothelial damage in the development of IE was mediated by neutrophil elastase. The present study implied that anti-elastase agents are possibly an effective therapeutic protocol for IE, but this needs further elucidation.